[1]
Ashari sukahar, A. 2023. RISK OF HBV REACTIVATION DURING THERAPIES FOR HCC: A SYSTEMATIC REVIEW. Journal of Advanced Research in Medical and Health Science (ISSN 2208-2425). 9, 10 (Oct. 2023), 111–116. DOI:https://doi.org/10.53555/t0qwb657.